Walgreens Boots Alliance
Retail Pharmacy & HealthcareFounded 1901- Updated July 2025
Reviewed by Swet Parvadiya
Last reviewed: July 2025
CorpDigest
Walgreens Boots Alliance
Company History
Founded 1901 in Deerfield, Illinois
Last reviewed: 2025-07-15 · By Swet Parvadiya
Walgreens Boots Alliance is a Retail Pharmacy & Healthcare company with $147.7B in 2024 revenue and 312K employees worldwide. Walgreens Boots Alliance occupies a unique and complicated position in the American economic landscape. It is simultaneously one of the most physically accessible healthcare touchpoints in the United States — within five miles of nearly four in five Americans — and one of the most financially stressed large-cap companies in the country. The company's 123-year operating history spans the entire arc of American pharmaceutical retail, from the apothecary era of the early twentieth century through the golden age of suburban drugstore expansion in the 1960s and 1970s, the managed care revolution of the 1980s and 1990s, the consolidation wave of the 2000s, and the digital disruption of the 2010s and 2020s. The Walgreens brand carries genuine cultural weight with American consumers. Survey data consistently shows Walgreens among the most recognized and trusted retail pharmacy brands in the country, a legacy of its century-plus presence in American communities and its role as a consistent provider of public health services including vaccinations, health screenings, and COVID-19 testing and treatment. This reservoir of brand trust is a real asset that purely transactional competitors cannot acquire quickly. The company's international presence through Boots UK adds a dimension of global relevance and brand portfolio depth that distinguishes WBA from purely domestic pharmacy competitors. Boots' No7 skincare brand and Advantage Card loyalty program represent examples of the kind of proprietary value creation that the U.S. Operations have not yet successfully replicated at scale. The fundamental challenge for WBA's management and, potentially, its future private equity owners is to honor this heritage while adapting aggressively to a healthcare landscape that rewards integration, data, and clinical outcomes over mere geographical convenience.
Charles R. Walgreen Sr. Is one of the most consequential figures in the history of American retail. A self-made entrepreneur who parlayed a borrowed $2,000 into one of the most recognized retail brands in American history, Walgreen combined pharmaceutical professionalism with retail showmanship in a way that had no direct precedent in the industry. He was an innovator in retail standardization, understanding decades before modern retail theory codified the concept that consumers valued consistency and predictability above novelty. His emphasis on the soda fountain as a traffic driver — ultimately contributing to the popularization of the malted milk shake — demonstrated his instinct for the experiential dimension of retail that mere merchandise display could not provide. He served as the company's chief executive until his death in 1939, having grown the company from a single Chicago storefront to a 500-plus location national chain.
Charles R. Walgreen Sr. Opens his first drugstore at 4134 South Cottage Grove Avenue in Chicago, Illinois, financed with $2,000 borrowed from his former employer. The store features a soda fountain that becomes central to its community appeal.
Walgreens operates nine stores in Chicago, establishing the management systems and centralized purchasing infrastructure that will support rapid expansion in the following decade.
The company completes its initial public offering, listing shares on the New York Stock Exchange and providing capital for continued national expansion. At the time of the IPO, Walgreens operates more than 100 stores.
By 1929, Walgreens has expanded to more than 525 locations across 87 cities, making it one of the fastest-growing retail chains in American history during the 1920s expansion era.
Walgreens opens its 1,000th store, reflecting decades of disciplined organic growth and establishing the company as the largest pharmacy chain in the United States by store count at the time.
The company reaches 6,000 U.S. Pharmacy locations, cementing its position as the country's second-largest pharmacy chain and one of the most geographically accessible retail healthcare networks in the world.
Walgreens acquires a 45 percent stake in Alliance Boots GmbH, a leading European pharmacy and pharmaceutical wholesale company, for approximately 6.7 billion dollars, beginning the multinational transformation of the company.
Walgreens completes the full acquisition of Alliance Boots, forming Walgreens Boots Alliance and creating one of the largest pharmacy-led health and beauty retail and pharmaceutical wholesale companies in the world with operations across more than a dozen countries.
After a blocked attempt to acquire all of Rite Aid Corporation, WBA completes the acquisition of 1,932 Rite Aid stores and three distribution centers for approximately 4.375 billion dollars, significantly expanding its U.S. Pharmacy footprint.
WBA announces a 5.2 billion dollar investment to bring VillageMD primary care clinics to more than 600 Walgreens locations by 2025, representing the most ambitious healthcare services transformation effort in the company's history.
WBA recognizes multi-billion dollar goodwill impairment charges related to VillageMD, cuts its quarterly dividend, and appoints Tim Wentworth as CEO to lead a fundamental strategic reset focused on core pharmacy operations.
WBA announces plans to close approximately 1,200 U.S. Stores over a three-year period as part of a comprehensive restructuring program. The company's stock falls more than 70 percent during calendar year 2024, and its credit rating is cut to non-investment grade by major ratings agencies.
The acquisition of Alliance Boots was the most transformative strategic transaction in Walgreens' history, converting a domestic U.S. Pharmacy chain into a global healthcare enterprise with operations across Europe, Latin America, and Asia. Walgreens management sought to create a business with sufficient scale to negotiate more favorable pharmaceutical procurement terms globally and to participate in the higher-margin European pharmacy and wholesale distribution markets. The transaction also positioned WBA as the first truly global pharmacy-led health and beauty company, a distinction that management hoped would create strategic value through geographic diversification and brand portfolio depth.
After a proposed acquisition of all of Rite Aid Corporation was blocked by antitrust regulators, WBA negotiated a revised transaction to acquire approximately 1,932 Rite Aid store locations and three distribution centers. The store acquisition was intended to fill geographic gaps in the Walgreens U.S. Network and to achieve the scale economies available from operating a larger total store count across the same overhead infrastructure. The Rite Aid stores were concentrated in the Northeast and Southeast, markets where Walgreens had historically been underrepresented relative to CVS.
WBA announced a commitment to invest approximately 5.2 billion dollars in VillageMD, a primary care clinic operator, over five years to co-locate VillageMD primary care practices inside Walgreens pharmacy locations. The strategy was designed to transform the Walgreens network from a prescription dispensing point into a comprehensive healthcare destination, capitalizing on the patient trust and visit frequency generated by the pharmacy relationship to drive primary care utilization. Management believed that the combination of pharmacy access and primary care services under one roof would attract health plan contracts and generate clinical revenue independent of PBM reimbursement dynamics.
WBA acquired the majority of the Alliance Healthcare pharmaceutical wholesale distribution business from AmerisourceBergen in 2021, deepening its European pharmaceutical distribution footprint and increasing its participation in the wholesale logistics business that serves pharmacies, hospitals, and healthcare providers across Europe. The acquisition was intended to strengthen WBA's position as a pharmaceutical supply chain partner and to capture more of the economic value created along the pharmaceutical distribution chain from manufacturer to patient.
Shields Health Solutions is a specialty pharmacy services company that partners with health systems to operate specialty pharmacy programs within hospital and health system settings, capturing prescription volume that would otherwise be filled at external specialty pharmacies. WBA acquired a majority stake in Shields as part of its broader healthcare services expansion strategy, seeking to participate in the high-margin specialty pharmacy segment while simultaneously building a health system partnership channel that could generate referral volume for Walgreens specialty pharmacy locations.